Advanced search
Publication Cover
Journal of Medical Economics Volume 23, 2020 - Issue 12
Submit an article Journal homepage
4,365
Views
6
CrossRef citations to date
0
Altmetric
Respiratory Medicine

Updated cost-effectiveness analysis of palivizumab (Synagis) for the prophylaxis of respiratory syncytial virus in infant populations in the UK

Omendra Narayana Royal Manchester Children’s Hospital, Manchester, UK;b Paediatric Respiratory Medicine, University of Manchester, Manchester, UK
,
Anthony Bentleyc Mtech Access Limited, Bicester, UK
,
Katie Mowbrayd AbbVie Limited, Maidenhead, UK
,
Monika Hermanssond AbbVie Limited, Maidenhead, UK
,
Dominic Pivonkad AbbVie Limited, Maidenhead, UK
,
Eric Ngonga Kemadjoue JB Medical Limited, Sudbury, UKCorrespondence[email protected]
&
Jonathan Belseye JB Medical Limited, Sudbury, UK
 show all
Pages 1640-1652 | Received 06 Aug 2020, Accepted 05 Oct 2020, Published online: 27 Oct 2020

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.